Pliant Therapeutics Inc. (PLRX)
12.10
0.86 (7.65%)
At close: Jan 15, 2025, 1:57 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -6.59 | -6.68 | -27.02 | -20.32 | 4.09K | -11.62 | -0.83 |
| PS Ratio | 673.04 | 83.86 | 63.91 | 19.32 | 13.27 | n/a | n/a |
| PB Ratio | 2.25 | 2.59 | 2.43 | 2.85 | -1.74K | -398.71 | 5.12 |
| P/FCF Ratio | -9.07 | -8.43 | -6.25 | -20.82 | -203.89 | -11.47 | -0.93 |
| P/OCF Ratio | -9.14 | -8.58 | -6.41 | -21.67 | -275.36 | -12.41 | -1.01 |
| OCF/S Ratio | -73.65 | -9.77 | -9.96 | -0.89 | -0.05 | n/a | n/a |
| Debt / Equity Ratio | 0.02 | 0.05 | 0.04 | 0.00 | -1.02 | -0.6 | n/a |
| Quick Ratio | 17.72 | 14.23 | 12.44 | 25.07 | 13.69 | 12.14 | 1.48 |
| Current Ratio | 17.72 | 14.23 | 12.44 | 25.07 | 13.69 | 12.14 | 1.48 |
| Asset Turnover | 0.00 | 0.03 | 0.03 | 0.14 | 0.48 | n/a | n/a |
| Interest Coverage | -145.34 | -160.81 | -73.48 | -113.78 | -5.7 | n/a | n/a |
| Return on Equity (ROE) | -0.34 | -0.39 | -0.09 | -0.14 | -0.43 | 34.33 | -6.17 |
| Return on Assets (ROA) | -0.32 | -0.35 | -0.08 | -0.13 | 0.00 | -0.46 | -3.15 |
| Return on Capital (ROIC) | -0.38 | -0.39 | -0.1 | -0.15 | -0.01 | -0.5 | -5.45 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 61.99% | 57.69% | 100.00% | 100.00% | n/a | n/a |
| Net Profit Margin | -10.21K% | -1.25K% | -236.49% | -95.05% | 0.32% | n/a | n/a |
| Pretax Profit Margin | -10.21K% | -1.27K% | -260.35% | -99.32% | -1.11% | n/a | n/a |
| Operating Profit Margin | -11.65K% | -1.31K% | -263.95% | -99.59% | -2.16% | n/a | n/a |
| FCF Margin | -7.42K% | -995.26% | -1.02K% | -92.79% | -6.51% | n/a | n/a |
| EBITDA Margin | -10.01K% | -1.23K% | -1.26K% | -96.46% | -0.21% | n/a | n/a |